--- title: "Domestic cardiac surgery robot achieves clinical success, robot ETF ChinaAMC experiences fluctuations and weakness" type: "News" locale: "en" url: "https://longbridge.com/en/news/281834424.md" description: "The domestic cardiac surgery robot completed its first clinical surgery in Hong Kong, showing significant clinical benefits. Meanwhile, the robot ETF ChinaAMC (562500) experienced fluctuations today, with the latest price at 0.909 yuan, down 0.329% from the previous trading day. The performance of constituent stocks was mixed, with PHUA LEE MING hitting the limit up, while CSG Technology fell over 3%. Liquidity has increased, with a transaction volume of 222 million yuan and a turnover rate of 1.07%. It is recommended that investors manage their positions during the volatile period, lock in quality chips, and patiently wait for market sentiment to stabilize" datetime: "2026-04-07T05:54:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281834424.md) - [en](https://longbridge.com/en/news/281834424.md) - [zh-HK](https://longbridge.com/zh-HK/news/281834424.md) --- # Domestic cardiac surgery robot achieves clinical success, robot ETF ChinaAMC experiences fluctuations and weakness As of today at 13:44, the ChinaAMC CSI Robot ETF (562500) showed a fluctuating downward trend after opening, with the latest price reported at 0.909 yuan, down 0.329% from the previous trading day's closing price. In terms of holdings, the constituent stocks tracked by this ETF exhibited significant structural differentiation: PHUA LEE MING hit the daily limit and led the gains, Tianzhun Technology rose over 5%, and Bojie Co., Ltd. increased nearly 4%. Most constituent stocks showed mixed performance, with CSG Technology down over 3%, but overall, the index performance was suppressed by the weakness of heavyweight stocks. In terms of liquidity, the trading activity of this ETF significantly increased, with a transaction amount reaching 222 million yuan and a turnover rate of 1.07%, indicating a strong willingness of market participants to trade during the fluctuating market. In terms of funds, there was a net inflow of 23 million yuan yesterday. The current trend is in the afternoon's fluctuating downward phase, with the intraday line continuously shifting downward and turning negative after a morning peak, reflecting intensified competition between bulls and bears at this position, with selling pressure becoming apparent above. Strategically, it is recommended that investors maintain strategic composure and manage their positions during the fluctuation period before the trend is established. Against the backdrop of the continuous evolution of the embodied intelligence industry logic, investors can orderly lock in quality stocks with attractive valuations during the intraday fluctuation window and patiently wait for opportunities for sustained rebounds after market sentiment stabilizes completely. In terms of news, the domestic robot-assisted transcatheter tricuspid valve replacement system, developed by the Institute of Automation of the Chinese Academy of Sciences, completed its first clinical heart valve surgery on March 27 at Prince of Wales Hospital in Hong Kong. The surgery was performed by a team from the Chinese University of Hong Kong's Faculty of Medicine, successfully implanting a valve for a patient with severe tricuspid regurgitation, with the regurgitation disappearing post-surgery and the patient's recovery status being good. Cathay Securities pointed out that surgical robots have significant clinical benefits, and the global penetration rate is expected to continue to rise. Domestic manufacturers' products have outstanding clinical data, and the advantages of Chinese manufacturing bring higher cost-effectiveness, which is expected to capture global market share through differentiated advantages. The ChinaAMC CSI Robot ETF (562500) is the only robot-themed ETF in the entire market with a scale exceeding 20 billion, covering multiple sub-sectors such as humanoid robots, industrial robots, and service robots, helping investors to easily layout the upstream and downstream industrial chain of robots. Off-market connections (ChinaAMC CSI Robot ETF Initiated Connection A: 018344; ChinaAMC CSI Robot ETF Initiated Connection C: 018345). The commercialization of humanoid robots is approaching, and the ChinaAMC CSI Robot ETF (562500) is highly focused on the humanoid robot industrial chain. The index's heavyweight stocks have significant first-mover advantages in embodied intelligence, core component localization, and mass production process iteration, helping investors accurately grasp the industrial dividends as the robot sector transitions from "technology validation" to "scale implementation." ### Related Stocks - [688248.CN](https://longbridge.com/en/quote/688248.CN.md) - [562500.CN](https://longbridge.com/en/quote/562500.CN.md) - [002957.CN](https://longbridge.com/en/quote/002957.CN.md) ## Related News & Research - [ElliQ is a surprisingly helpful companion robot for older adults](https://longbridge.com/en/news/286673621.md) - [Chef Introduces Deposit Assist Capability for More Precise Deposits into Small Compartments and Inserts](https://longbridge.com/en/news/286947806.md) - [Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology](https://longbridge.com/en/news/286769909.md) - [Unitree Robotics and DEEP Robotics Accelerate IPO Progress; Shoucheng Holdings' Robotics Investments Enter a Value Validation Phase](https://longbridge.com/en/news/286853966.md) - [Unitree Unveils Real-Life Transformer Robot. Only Costs $650,000](https://longbridge.com/en/news/286499815.md)